- Home
- MRAM vs PEPG Comparison
MRAM vs PEPG Comparison
Compare MRAM & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- PEPG
- Stock Information
- Founded
- MRAM 2008
- PEPG 2018
- Country
- MRAM United States
- PEPG United States
- Employees
- MRAM N/A
- PEPG N/A
- Industry
- MRAM Semiconductors
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- PEPG Health Care
- Exchange
- MRAM Nasdaq
- PEPG Nasdaq
- Market Cap
- MRAM 140.4M
- PEPG 147.0M
- IPO Year
- MRAM 2016
- PEPG 2022
- Fundamental
- Price
- MRAM $6.48
- PEPG $4.40
- Analyst Decision
- MRAM Strong Buy
- PEPG Buy
- Analyst Count
- MRAM 2
- PEPG 3
- Target Price
- MRAM $9.00
- PEPG $14.67
- AVG Volume (30 Days)
- MRAM 105.3K
- PEPG 215.7K
- Earning Date
- MRAM 10-30-2024
- PEPG 11-07-2024
- Dividend Yield
- MRAM N/A
- PEPG N/A
- EPS Growth
- MRAM N/A
- PEPG N/A
- EPS
- MRAM 0.07
- PEPG N/A
- Revenue
- MRAM $53,865,000.00
- PEPG N/A
- Revenue This Year
- MRAM N/A
- PEPG N/A
- Revenue Next Year
- MRAM $7.15
- PEPG N/A
- P/E Ratio
- MRAM $88.20
- PEPG N/A
- Revenue Growth
- MRAM N/A
- PEPG N/A
- 52 Week Low
- MRAM $4.89
- PEPG $2.90
- 52 Week High
- MRAM $9.43
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- MRAM 49.65
- PEPG 35.54
- Support Level
- MRAM $6.30
- PEPG $2.90
- Resistance Level
- MRAM $6.67
- PEPG $5.72
- Average True Range (ATR)
- MRAM 0.23
- PEPG 0.71
- MACD
- MRAM 0.00
- PEPG -0.03
- Stochastic Oscillator
- MRAM 30.02
- PEPG 37.97
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.